| Primary |
| Smoking Cessation Therapy |
77.0% |
| Blood Cholesterol Increased |
2.5% |
| Depression |
2.5% |
| Diabetes Mellitus |
2.5% |
| Bipolar Disorder |
1.9% |
| Antidepressant Therapy |
1.2% |
| Asthma |
1.2% |
| Blood Pressure Abnormal |
1.2% |
| Ex-smoker |
1.2% |
| Insomnia |
1.2% |
| Pain |
1.2% |
| Thyroid Disorder |
1.2% |
| Abdominal Discomfort |
0.6% |
| Blood Cholesterol Abnormal |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Gastrointestinal Infection |
0.6% |
| Hepatitis C |
0.6% |
| Hypertension |
0.6% |
| Migraine |
0.6% |
| Nicotine Dependence |
0.6% |
|
| Treatment Noncompliance |
20.5% |
| Death |
8.2% |
| Nausea |
8.2% |
| Palpitations |
6.8% |
| Rash |
5.5% |
| Syncope |
5.5% |
| Vomiting |
5.5% |
| Dyspnoea |
4.1% |
| Night Sweats |
4.1% |
| Stress |
4.1% |
| Ageusia |
2.7% |
| Dizziness |
2.7% |
| Feeling Abnormal |
2.7% |
| Hypertension |
2.7% |
| Hypotension |
2.7% |
| Insomnia |
2.7% |
| Malaise |
2.7% |
| Myocardial Infarction |
2.7% |
| Pruritus |
2.7% |
| Somnolence |
2.7% |
|
| Secondary |
| Smoking Cessation Therapy |
69.5% |
| Blood Cholesterol Abnormal |
3.7% |
| Blood Cholesterol Increased |
3.7% |
| Blood Pressure Abnormal |
3.7% |
| Depression |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Thyroid Disorder |
2.4% |
| Abdominal Discomfort |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Diabetes Mellitus |
1.2% |
| Gastrointestinal Infection |
1.2% |
| Heart Rate Increased |
1.2% |
| Pruritus |
1.2% |
| Schizophrenia |
1.2% |
| Sleep Disorder |
1.2% |
| Stress |
1.2% |
| Tooth Infection |
1.2% |
|
| Treatment Noncompliance |
18.6% |
| Suicidal Ideation |
14.0% |
| Memory Impairment |
7.0% |
| Thinking Abnormal |
7.0% |
| Haematemesis |
4.7% |
| Hypotension |
4.7% |
| Nightmare |
4.7% |
| Overdose |
4.7% |
| Pruritus |
4.7% |
| Pruritus Generalised |
4.7% |
| Sleep Apnoea Syndrome |
4.7% |
| Application Site Erythema |
2.3% |
| Blood Creatinine Increased |
2.3% |
| Death |
2.3% |
| Dyspnoea |
2.3% |
| Inappropriate Schedule Of Drug Administration |
2.3% |
| Insomnia |
2.3% |
| Myalgia |
2.3% |
| Nausea |
2.3% |
| Product Quality Issue |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.7% |
| Drug Use For Unknown Indication |
13.9% |
| Osteomyelitis |
5.4% |
| Eczema |
3.1% |
| Smoking Cessation Therapy |
2.7% |
| Contraception |
2.4% |
| Schizophrenia |
2.4% |
| Hyperlipidaemia |
2.0% |
| Percutaneous Coronary Intervention |
2.0% |
| Premedication |
2.0% |
| Bone Cancer Metastatic |
1.7% |
| Breast Cancer |
1.7% |
| Metastases To Bone |
1.7% |
| Antiplatelet Therapy |
1.4% |
| Arteriogram Coronary |
1.4% |
| Blood Pressure Systolic Increased |
1.4% |
| Crohn's Disease |
1.4% |
| Haemodialysis |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Antibiotic Prophylaxis |
1.0% |
|
| Weight Decreased |
17.4% |
| Ventricular Fibrillation |
15.2% |
| Metastatic Neoplasm |
6.5% |
| Retinitis Pigmentosa |
6.5% |
| Vertebral Foraminal Stenosis |
6.5% |
| Vomiting |
6.5% |
| Calculus Ureteric |
4.3% |
| Psychiatric Decompensation |
4.3% |
| Renal Failure Acute |
4.3% |
| Upper Gastrointestinal Haemorrhage |
4.3% |
| Weight Increased |
4.3% |
| Arthritis |
2.2% |
| Chest Discomfort |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Deep Vein Thrombosis |
2.2% |
| Diabetes Mellitus |
2.2% |
| Drug Ineffective |
2.2% |
| Embolism Venous |
2.2% |
| Fear |
2.2% |
| Fluid Overload |
2.2% |
|
